Shanghai Rongtai Health Technology (SHSE:603579) Short-Term Debt: ¥435 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603579 Shanghai Rongtai Health Technology Corp Ltd SHSE:603579
69 GF Score
Price ¥18.22
GF Value ¥17.53
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Shanghai Rongtai Health Technology Short-Term Debt?

Shanghai Rongtai Health Technology SHSE:603579 +0.55% 69 Short-Term Debt is ¥435 Mil as of Jun. 2026. GuruFocus rates SHSE:603579 with a GF Score™ of 69/100 and a GF Value™ of ¥17.53 (Fairly Valued). The stock has 6 warning signs investors should review.

Shanghai Rongtai Health Technology's Short-Term Debt for the quarter that ended in Jun. 2026 was ¥435 Mil.

Shanghai Rongtai Health Technology's quarterly Short-Term Debt increased from Dec. 2025 (¥169 Mil) to Mar. 2026 (¥276 Mil) and increased from Mar. 2026 (¥276 Mil) to Jun. 2026 (¥435 Mil).

Shanghai Rongtai Health Technology's annual Short-Term Debt increased from Dec. 2023 (¥129 Mil) to Dec. 2024 (¥427 Mil) but then declined from Dec. 2024 (¥427 Mil) to Dec. 2025 (¥169 Mil).

Shanghai Rongtai Health Technology Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Shanghai Rongtai Health Technology Short-Term Debt Related Terms

Shanghai Rongtai Health Technology Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Shanghai Rongtai Health Technology's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Rongtai Health Technology Short-Term Debt Chart

Shanghai Rongtai Health Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 114.77 408.52 129.13 426.61 168.79

Shanghai Rongtai Health Technology Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 213.82 150.31 168.79 275.85 434.82
SHSE:603579
69GF Score
Shanghai Rongtai Health Technology Corp Ltd SHSE:603579
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of ¥435 Mil mean?
Shanghai Rongtai Health Technology (SHSE:603579) has a Short-Term Debt of ¥435 Mil as of Jun. 2026.
Is Shanghai Rongtai Health Technology's Short-Term Debt too high?
Shanghai Rongtai Health Technology's current Short-Term Debt is ¥435 Mil. Overall, Shanghai Rongtai Health Technology has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Rongtai Health Technology's Short-Term Debt compare to AS and HAS?
Shanghai Rongtai Health Technology's Short-Term Debt of ¥435 Mil can be compared against companies in the Travel & Leisure industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Travel & Leisure company?
A good Short-Term Debt depends on the Travel & Leisure industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Shanghai Rongtai Health Technology's current Short-Term Debt is ¥435 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Rongtai Health Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology (SHSE:603579) is currently considered Fairly Valued. The stock's GF Value™ is ¥17.53, compared to a current price of ¥18.22 — trading 3.9% above its estimated fair value. The current Short-Term Debt is ¥435 Mil. Shanghai Rongtai Health Technology's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Shanghai Rongtai Health Technology (SHSE:603579), the current Short-Term Debt is ¥435 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Rongtai Health Technology (SHSE:603579) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Rongtai Health Technology stock appears to be overvalued. The current stock price of ¥18.22 is trading 3.9% above its estimated GF Value™ of ¥17.53. GuruFocus considers Shanghai Rongtai Health Technology to be Fairly Valued.

Key valuation signals for SHSE:603579:

  • Short-Term Debt: ¥435 Mil
  • GF Value™: ¥17.53 vs. price of ¥18.22 (3.9% above fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the SHSE:603579 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Rongtai Health Technology Business Description

Address No. 1226 ZhuFeng Road, Qingpu District, Shanghai, CHN, 201702
Shanghai Rongtai Health Technology Corp Ltd is a China based company engaged in development, manufacturing and marketing of massage equipment. It also offers technology health solutions. The company's products include eye massager, massage chair series, mini massage chair, partial massage series products, massage stick, and waist massager.
69GF Score

Get the complete analysis for SHSE:603579

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.22
Price
¥17.53
GF Value